Diabetes accelerates the onset of severe long-term conditions by 15-20 years, cutting life expectancy

A study in Nature Medicine reveals that diabetes accelerates the onset of multiple long-term conditions by 15-20 years, significantly reducing life expectancy in English adults.

Flagship’s gene editing startup Tessera cuts jobs as it shifts resources to clinic

Tessera Therapeutics, Flagship’s major bet on what it calls gene writing, is letting go 13% to 14% of its workforce, a spokesperson confirmed to Endpoints

April 24, 2024

Hold Off a Bit Before Operating on Broken Hips, Study Suggests

SAN FRANCISCO — Hip fracture repair is best started about 20 hours after presentation in elderly patients on blood thinners, not immediately and not more

October 17, 2023

Editas sells future CRISPR license fees; Plus, news about Oncolytics Biotech

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.